|
|
Copyright © LARVOL 2024. All rights reserved. Visit ASCO 2022: A phase I/II study of ruxolitinib with frontline neoadjuvan (https://clin.larvol.com/abstract-detail/ASCO%202022/56545008)
|
Top Keywords: 2022, asco, a phase i, ii study of, ii study, a phase, phase i, i ii, study of, ruxolitinib, frontline, phase, ii, study, trials, influencers, conferences, i, a, reserved, terms of service, of service, patients with advanced, in patients with, all rights reserved, ovarian fallopian, 2022 a, figures for, epithelial ovarian, tube or, fallopian tube, post surgical, and post, with advanced, in patients, peritoneal cancer, Theres a total of 62 keywords.
Inbound and Outbound LinksThere is currently no known inbound links. There is currently no known outbound links. |
Statistics
We first found this page on 2023-03-18 23:40:02 +0000. It was last re-indexed on 2024-09-24 14:36:33 +0000 and with a fetch interval of 90 days it will be fetched again in 0 days on 2024-12-26 or soon thereafter.
Last fetch returned code 200, OK, the current page state is ACTIVE.
Traffic Data for clin.larvol.com
Traffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt
Similar Sites
Project Finder | Leukemia and Lymphoma Society
With hundreds of projects currently underway, we fund scientists through our academic grant programs and biotech partners through our strategic venture philanthropy initiative. Use the filters below to find an LLS-funded
https://www.lls.org/project-finder
- Details - Similar
Ac-225 rosopatamab tetraxetan (CONV01-α) / Weill Cornell Medical Colle
News for Ac-225 rosopatamab tetraxetan (CONV01-α) / Weill Cornell Medical College, Dominari Holdings
https://delta.larvol.com/Products/?ProductId=f26961cb-33dd-4f63-a62a-8c54c16fa4c7
- Details - Similar
E1903 Standard Practice for Environmental Site Assessments: Phase II
Significance and Use 4.1 Uses: 4.1.1 This practice is intended for use on a voluntary basis by parties who wish to evaluate known releases or likely release areas identified by the user or Phase II Assessor, and/or t
https://www.astm.org/e1903-19.html
- Details - Similar
pegilodecakin (LY3500518) / Eli Lilly
News for pegilodecakin (LY3500518) / Eli Lilly
https://delta.larvol.com/Products/?ProductId=f19283c2-cc63-4231-8e15-ec0207605e0f
- Details - Similar
More sites similar to ASCO 2022: A phase I/II study of ruxolitinib with frontline neoadjuvan...
Find Another Website
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less